Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Masafumi Nishio, Yoshito Ishii, Yu Hashimoto, Haruka Otake, Tsuyoshi Ogashiwa, Saya Tsuda, Hisae Yasuhara, Yusuke Saigusa, Hideaki Kimura, Shin Maeda & Reiko Kunisaki. (2018) Short- and long-term efficacy of adalimumab salvage therapy after failure of calcineurin inhibitors in steroid-refractory ulcerative colitis. Scandinavian Journal of Gastroenterology 53:10-11, pages 1236-1244.
Read now
Read now
Ji-Young Yang, Kyung-Wook Jo, Seokchan Hong, Bin Yoo, Chang-Keun Lee, Yong-Gil Kim, Suk-Kyun Yang, Jeong-Sik Byeon, Kyung-Jo Kim, Byong Duk Ye, Sang-Hyoung Park & Tae Sun Shim. (2016) Adequacy of initiating TNF antagonists within 3 weeks of starting latent tuberculosis infection treatment in patients with immune-mediated inflammatory diseases. Infectious Diseases 48:4, pages 293-298.
Read now
Read now
Articles from other publishers (21)
Ufuk İlgen, Ömer Karadağ, Hakan Emmungil, Orhan Küçükşahin, Süleyman Serdar Koca, Abdülsamet Erden, Cemal Bes, Nilüfer Alpay Kanıtez, Ediz Dalkılıç, Servet Akar, Rıdvan Mercan, Muhammet Çınar, Timuçin Kaşifoğlu, Emel Gönüllü, Gezmiş Kimyon, Duygu Ersözlü, Pamir Atagündüz, Levent Kılıç, İhsan Ertenli, Veli Yazısız, Aşkın Ateş, Sedat Kiraz & Umut Kalyoncu. (2022) Tuberculin skin test before biologic and targeted therapies: does the same rule apply for all?. Rheumatology International 42:10, pages 1797-1806.
Crossref
Crossref
Yagmur Kaptan, Asli Suner, Mehmet Nedim Taş, Fahrettin Oksel, Kenan Aksu & Abdullah Sayiner. (2021) Tuberculosis despite latent infection screening and treatment in patients receiving TNF inhibitor therapy. Clinical Rheumatology 40:9, pages 3783-3788.
Crossref
Crossref
T Kucharzik, P Ellul, T Greuter, J F Rahier, B Verstockt, C Abreu, A Albuquerque, M Allocca, M Esteve, F A Farraye, H Gordon, K Karmiris, U Kopylov, J Kirchgesner, E MacMahon, F Magro, C Maaser, L de Ridder, C Taxonera, M Toruner, L Tremblay, M Scharl, N Viget, Y Zabana & S Vavricka. (2021) ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease. Journal of Crohn's and Colitis 15:6, pages 879-913.
Crossref
Crossref
Farida Benhadou, Violette Dirix, Fanny Domont, Fabienne Willaert, Anne Van Praet, Camille Locht, Françoise Mascart & Véronique Corbière. (2021) Tuberculosis Risk Stratification of Psoriatic Patients Before Anti-TNF-α Treatment. Frontiers in Immunology 12.
Crossref
Crossref
Samra Rahman, Muhammad Irfan & M A Rehman Siddiqui. (2021)
Role of interferon gamma release assay in the diagnosis and management of
Mycobacterium tuberculosis
-associated uveitis: a review
. BMJ Open Ophthalmology 6:1, pages e000663.
Crossref
Crossref
Guozhong Zhou, Qingyi Luo, Shiqi Luo, Zhaowei Teng, Zhenhua Ji, Jiaru Yang, Feng Wang, Shiyuan Wen, Zhe Ding, Lianbao Li, Taigui Chen, Manzama-Esso Abi, Miaomiao Jian, Lisha Luo, Aihua Liu & Fukai Bao. (2020) Interferon-γ release assays or tuberculin skin test for detection and management of latent tuberculosis infection: a systematic review and meta-analysis. The Lancet Infectious Diseases 20:12, pages 1457-1469.
Crossref
Crossref
So Hye Nam, Ji Seon Oh, Seokchan Hong, Tae Sun Shim, Chang-Keun Lee, Bin Yoo & Yong-Gil Kim. (2020) Early discontinuation of tofacitinib in patients with rheumatoid arthritis co-treated with rifampin for latent tuberculosis. Joint Bone Spine 87:5, pages 475-479.
Crossref
Crossref
Liliana Pereira Carvalho, Maria Ana Túlio, José Pedro Rodrigues, Tiago Bana e Costa & Cristina Chagas. (2019) Miliary Tuberculosis in a Crohn’s Disease Patient: The Risk beyond the Screening. GE - Portuguese Journal of Gastroenterology 26:1, pages 64-69.
Crossref
Crossref
Ibrahim Abubakar, Ajit Lalvani, Jo Southern, Alice Sitch, Charlotte Jackson, Oluchukwu Onyimadu, Marc Lipman, Jonathan J Deeks, Chris Griffiths, Graham Bothamley, Onn Min Kon, Andrew Hayward, Joanne Lord & Francis Drobniewski. (2018) Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study. Health Technology Assessment 22:56, pages 1-96.
Crossref
Crossref
Jieun Kang, Dae Hyun Jeong, Bin Yoo, Chang-Keun Lee, Yong-Gil Kim, Seokchan Hong, Tae Sun Shim & Kyung-Wook Jo. (2018) The usefulness of routine chest radiograph examinations in patients treated with TNF inhibitors for inflammatory arthritis in South Korea. Respiratory Medicine 143, pages 109-115.
Crossref
Crossref
Dong Il ParkTadakazu HisamatsuMinhu ChenSiew Chien NgChoon Jin OoiShu Chen WeiRupa BanerjeeIda Normiha HilmiYoon Tae JeenDong Soo HanHyo Jong KimZhihua RanKaichun WuJiaming QianPin-Jin HuKatsuyoshi MatsuokaAkira AndohYasuo SuzukiKentaro SuganoMamoru WatanabeToshifumi HibiAmarender S. PuriSuk-Kyun Yang. (2018) Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: risk assessment. Intestinal Research 16:1, pages 4.
Crossref
Crossref
Dong II Park, Tadakazu Hisamatsu, Minhu Chen, Siew Chien Ng, Choon Jin Ooi, Shu Chen Wei, Rupa Banerjee, Ida Normiha Hilmi, Yoon Tae Jeen, Dong Soo Han, Hyo Jong Kim, Zhihua Ran, Kaichun Wu, Jiaming Qian, Pin-Jin Hu, Katsuyoshi Matsuoka, Akira Andoh, Yasuo Suzuki, Kentaro Sugano, Mamoru Watanabe, Toshifumi Hibi, Amarender S Puri & Suk-Kyun Yang. (2018) Asian Organization for Crohn's and Colitis and Asian Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: Risk assessment. Journal of Gastroenterology and Hepatology 33:1, pages 20-29.
Crossref
Crossref
Irene Latorre, Sonia Mínguez, José-Manuel Carrascosa, Juan Naves, Raquel Villar-Hernández, Beatriz Muriel, Cristina Prat, Esther García-García, Irma Casas, Eugeni Domènech, Carlos Ferrándiz, Lourdes Mateo & Jose Domínguez. (2017) Immune-mediated inflammatory diseases differently affect IGRAs’ accuracy for latent tuberculosis infection diagnosis in clinical practice. PLOS ONE 12:12, pages e0189202.
Crossref
Crossref
Tan N. Doan, Damon P. Eisen, Morgan T. Rose, Andrew Slack, Grace Stearnes & Emma S. McBryde. (2017) Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: A latent-class analysis. PLOS ONE 12:11, pages e0188631.
Crossref
Crossref
Eun Hye Lee, Young Ae Kang, Ah Young Leem, Moo Suk Park, Young Sam Kim, Se Kyu Kim, Joon Chang & Song Yee Kim. (2017) Active Tuberculosis Incidence and Characteristics in Patients Treated with Tumor Necrosis Factor Antagonists According to Latent Tuberculosis Infection. Scientific Reports 7:1.
Crossref
Crossref
Hamid Reza Naderi, Fereshte Sheybani & Susan Rezaei Pajand. (2016) How Should We Manage Latent Tuberculosis Infection in Patients Receiving Anti-TNF-α Drugs: Literature Review. Iranian Red Crescent Medical Journal 18:12.
Crossref
Crossref
Patricia J. Simner, Gail L. Woods & Nancy L. Wengenack. 2016. Diagnostic Microbiology of the Immunocompromised Host. Diagnostic Microbiology of the Immunocompromised Host
367
389
.
Patricia J. Simner, Gail L. Woods & Nancy L. Wengenack. (2016) Mycobacteria. Microbiology Spectrum 4:4.
Crossref
Crossref
Sang Hyoung Park, Sung Wook Hwang, Min Seob Kwak, Wan Soo Kim, Jeong-Mi Lee, Ho-Su Lee, Dong-Hoon Yang, Kyung-Jo Kim, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Yong Sik Yoon, Chang Sik Yu, Jin-Ho Kim & Suk-Kyun Yang. (2016) Long-Term Outcomes of Infliximab Treatment in 582 Korean Patients with Crohn’s Disease: A Hospital-Based Cohort Study. Digestive Diseases and Sciences 61:7, pages 2060-2067.
Crossref
Crossref
Jung-Wan Yoo, Kyung-Wook Jo, Gu Young Park & Tae Sun Shim. (2016) Comparison of latent tuberculosis infection rate between contacts with active tuberculosis and non-contacts. Respiratory Medicine 111, pages 77-83.
Crossref
Crossref
Fabrizio Cantini, Carlotta Nannini, Laura Niccoli, Florenzo Iannone, Giovanni Delogu, Giacomo Garlaschi, Alessandro Sanduzzi, Andrea Matucci, Francesca Prignano, Michele Conversano & Delia Goletti. (2015) Guidance for the management of patients with latent tuberculosis infection requiring biologic therapy in rheumatology and dermatology clinical practice. Autoimmunity Reviews 14:6, pages 503-509.
Crossref
Crossref